Fructose and mannose metabolism |
3.54 |
Type I diabetes mellitus |
2.74 |
*ABC transporters |
−2.25 |
Cytokine-cytokine receptor interaction
|
3.4 |
DNA polymerase |
2.73 |
*B cell receptor signaling pathway |
−2.25 |
Complement and coagulation cascades
|
3.37 |
*N-Glycan biosynthesis |
2.73 |
*Non-small cell lung cancer |
−2.25 |
Hedgehog signaling pathway |
3.3 |
RNA polymerase |
2.73 |
*Chronic myeloid leukemia |
−2.26 |
*Biosynthesis of steroids |
3.29 |
Gap junction |
2.72 |
*Melanoma |
−2.28 |
Riboflavin metabolism |
3.26 |
*Type II diabetes mellitus |
2.72 |
*Renal cell carcinoma |
−2.28 |
*Circadian rhythm |
3.24 |
Inositol metabolism |
2.71 |
*Biotin metabolism |
−2.29 |
Starch and sucrose metabolism
|
3.23 |
*mTOR signaling pathway |
2.7 |
*Terpenoid biosynthesis |
−2.29 |
*Alzheimer's disease |
3.22 |
PPAR signaling pathway
|
2.66 |
*VEGF signaling pathway |
−2.31 |
Melanogenesis
|
3.21 |
ErbB signaling pathway |
2.64 |
*Valine, leucine and isoleucine biosynthesis |
−2.32 |
One carbon pool by folate
|
3.21 |
*Taste transduction |
2.64 |
*Linoleic acid metabolism |
−2.37 |
Wnt signaling pathway |
3.15 |
Tyrosine metabolism
|
2.64 |
*Aminoacyl-tRNA biosynthesis |
−2.39 |
TGF-beta signaling pathway |
3.08 |
*Sphingolipid metabolism |
2.63 |
*Glioma |
−2.4 |
Basal cell carcinoma
|
3.07 |
*Cell adhesion molecules (CAMs) |
2.56 |
Small cell lung cancer |
−2.42 |
*Aminosugars metabolism |
3.06 |
Phenylalanine metabolism |
2.55 |
*Colorectal cancer |
−2.43 |
Cell Communication
|
3.06 |
*Epithelial cell signaling Helicobacter pylori infection |
2.53 |
Proteasome |
−2.45 |
Long-term potentiation
|
3.06 |
*Phenylalanine, tyrosine & tryptophan biosynthesis |
2.52 |
Propanoate metabolism |
−2.5 |
CD40L Signaling Pathway
|
3.03 |
*Cholera |
2.51 |
Lysine degradation |
−2.51 |
Hematopoietic cell lineage
|
3.03 |
*Glutamate metabolism |
2.51 |
Porphyrin and chlorophyll metabolism |
−2.61 |
Pyruvate metabolism
|
3.03 |
Alkaloid biosynthesis I |
2.49 |
Carbon fixation |
−2.62 |
ECM-receptor interaction |
3.02 |
Pathogenic Escherichia coli infection
|
2.49 |
Citrate cycle (TCA cycle)
|
−2.63 |
Olfactory transduction |
3.01 |
Acute myeloid leukemia
|
2.48 |
Axon guidance |
−2.64 |
Neuroactive ligand-receptor interaction
|
2.99 |
Stilbene, coumarine and lignin biosynthesis |
2.48 |
*gamma-Hexachlorocyclohexane degradation |
−2.64 |
Glycan structures - biosynthesis 1 |
2.98 |
Reductive carboxylate cycle (CO2 fixation) |
2.47 |
*Leukocyte transendothelial migration |
−2.7 |
Chondroitin sulfate biosynthesis |
2.96 |
Alanine and aspartate metabolism |
2.44 |
*D-Glutamine and D-glutamate metabolism |
−2.73 |
Folate biosynthesis
|
2.96 |
GnRH signaling pathway |
2.42 |
Cytokine Inflammatory Response |
−2.77 |
Pentose and glucuronate interconversions
|
2.93 |
*Pyrimidine metabolism |
2.41 |
*Cell cycle |
−2.81 |
*Galactose metabolism |
2.92 |
Parkinson's disease |
2.39 |
Tetrachloroethene degradation
|
−2.82 |
Jak-STAT signaling pathway |
2.91 |
Methionine metabolism |
2.37 |
Oxidative phosphorylation |
−2.88 |
Arachidonic acid metabolism |
2.9 |
Bile acid biosynthesis
|
2.36 |
microtubule-associated protein 1A
|
−3.3 |
*Protein export |
2.89 |
Peptidoglycan biosynthesis |
2.36 |
*Thiamine metabolism |
−3.3 |
Endometrial cancer
|
2.86 |
*Valine, leucine and isoleucine degradation |
2.36 |
|
|
Regulation of actin cytoskeleton |
2.86 |
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis
|
2.35 |
|
|
Toll-like receptor signaling pathway
|
2.85 |
*MAPK signaling pathway |
2.35 |
|
|
Butanoate metabolism
|
2.84 |
*Prostate cancer |
2.35 |
|
|
C5-Branched dibasic acid metabolism |
2.84 |
*Bladder cancer |
2.33 |
|
|
Glycine, serine and threonine metabolism
|
2.84 |
Inositol phosphate metabolism |
2.33 |
|
|
Adipocytokine signaling pathway
|
2.83 |
*Novobiocin biosynthesis |
2.33 |
|
|
Glycolysis/Gluconeogenesis
|
2.82 |
*Monoterpenoid biosynthesis |
2.32 |
|
|
*Glycerolipid metabolism |
2.8 |
*Apoptosis |
2.3 |
|
|
Calcium signaling pathway
|
2.78 |
Thyroid cancer |
2.29 |
|
|
Purine metabolism |
2.77 |
Regulation of autophagy |
2.28 |
|
|
Synthesis and degradation of ketone bodies |
2.76 |
Arginine and proline metabolism |
2.26 |
|
|